Zoetis (ZTS) Cash from Operations Growth (5y) (2017 - 2026)
Zoetis (ZTS) Cash from Operations Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn |
| 3 | Zoetis | 32.44 Bn | 30.50 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.05% |
| Dec 31, 2025 | 4.46% |
| Sep 30, 2025 | 10.79% |
| Jun 30, 2025 | 4.96% |
| Mar 31, 2025 | 4.77% |
| Dec 31, 2024 | 9.23% |
| Sep 30, 2024 | 13.45% |
| Jun 30, 2024 | 9.56% |
| Mar 31, 2024 | 8.87% |
| Dec 31, 2023 | 8.96% |
| Sep 30, 2023 | 5.65% |
| Jun 30, 2023 | -7.28% |
| Mar 31, 2023 | 7.13% |
| Dec 31, 2022 | 4.04% |
| Sep 30, 2022 | 3.68% |
| Jun 30, 2022 | 13.30% |
| Mar 31, 2022 | 21.03% |
| Dec 31, 2021 | 18.88% |
| Sep 30, 2021 | 22.27% |
| Jun 30, 2021 | 28.55% |